Viewing Study NCT00034268


Ignite Creation Date: 2025-12-24 @ 5:59 PM
Ignite Modification Date: 2025-12-28 @ 3:39 PM
Study NCT ID: NCT00034268
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2002-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module